-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Unity Biotechnology, Maintains $4 Price Target

Benzinga·04/23/2025 10:43:00
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield reiterates Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $4 price target.